SCHEMBL263667

SCHEMBL263667

CCC(CC)C(=O)CP(=O)(O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LAP3 P28838 1/20 0.42
TSHR P16473 2/20 0.42
MEN1 O00255 1/20 0.42
LMNA P02545 1/20 0.42
HPGD P15428 1/20 0.42
BLM P54132 1/20 0.42
KMT2A Q03164 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
USP2 O75604 1/20 0.41
FDPS P14324 3/20 0.37
ENO1 P06733 1/20 0.37
MMP1 P03956 2/20 0.37
MMP2 P08253 2/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
MMP8 P22894 1/20 0.37
CA9 Q16790 1/20 0.37
GCLC P48506 1/20 0.36
PGK1 P00558 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7196405 0.83 TSHR (0.34) LAP3TSHRMEN1LMNAHPGD
SCHEMBL2994534 0.81 FDPS (0.50) LAP3TSHRMEN1LMNAHPGD
SCHEMBL2991836 0.76 FOLH1 (0.39) LAP3TSHRTDP1USP2FDPS
SCHEMBL14285857 0.75 USP2 (0.50) TSHRMEN1KMT2ATDP1USP2
Potassium SCHEMBL31652342 0.75 USP2 (0.50) TSHRMEN1KMT2ATDP1USP2
SCHEMBL147193 0.74 TDP1 (0.46) LAP3TSHRMEN1LMNAHPGD
SCHEMBL2990606 0.73 LPAR3 (0.45) LMNABLMTDP1
SCHEMBL14617621 0.72 TDP1 (0.43) LAP3TSHRMEN1LMNAHPGD
SCHEMBL11118063 0.70 TDP1 (0.42) LAP3TSHRMEN1LMNAHPGD
SCHEMBL1304145 0.70 FOLH1 (0.64) CA2GCLC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240400793-A1 COMPOSITION FOR POLYURETHANE FOAM, FOAM PREPARED THEREFROM AND A METHOD THEREOF MOMENTIVE PERFORMANCE MATERIALS INC. 2024-12-05 US claimed
EP-4396271-A1 COMPOSITION FOR POLYURETHANE FOAM, FOAM PREPARED THEREFROM AND A METHOD THEREOF Momentive Performance Materials Inc. (US) 2024-07-10 EP claimed
WO-2023034354-A1 COMPOSITION FOR POLYURETHANE FOAM, FOAM PREPARED THEREFROM AND A METHOD THEREOF MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2023-03-09 WO claimed
EP-2545583-B1 METHODS AND COMPOSITIONS FOR DOPING SILICON SUBSTRATES WITH MOLECULAR MONOLAYERS VERSUM MAT US LLC (US) 2020-05-13 EP claimed
US-20100101651-A1 POLYMER SOLAR CELLS INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2010-04-29 US claimed
US-20260002280-A1 COMPOSITION FOR TIN OR TIN ALLOY ELECTROPLATING COMPRISING LEVELING AGENT BASF SE (DE) 2026-01-01 US disclosed
US-20250093270-A1 Method for Detecting Enzyme Activity and Fluorescent Probe Used in Said Method THE UNIVERSITY OF TOKYO (JP) 2025-03-20 US disclosed
EP-4488379-A1 METHOD FOR DETECTING ENZYME ACTIVITY AND FLUORESCENT PROBE USED IN SAID METHOD The University of Tokyo (JP) 2025-01-08 EP disclosed
WO-2024262824-A1 NOVEL PROCESS FOR SYNTHESIS OF POLYSUBSTITUTED PYRIDINE DERIVATIVES 서울대학교산학협력단 2024-12-26 WO disclosed
US-20240400793-A1 COMPOSITION FOR POLYURETHANE FOAM, FOAM PREPARED THEREFROM AND A METHOD THEREOF MOMENTIVE PERFORMANCE MATERIALS INC. 2024-12-05 US disclosed
EP-4396271-A1 COMPOSITION FOR POLYURETHANE FOAM, FOAM PREPARED THEREFROM AND A METHOD THEREOF Momentive Performance Materials Inc. (US) 2024-07-10 EP disclosed
WO-2024022979-A1 COMPOSITION FOR TIN OR TIN ALLOY ELECTROPLATING COMPRISING LEVELING AGENT BASF SE (DE) 2024-02-01 WO disclosed
WO-2000008068-A1 COMPOSITIONS SUITABLE FOR ELECTROCHEMICAL CELLS BASF AKTIENGESELLSCHAFT (DE) 2000-02-17 WO disclosed
WO-1999057161-A1 COMPOSITIONS SUITABLE FOR ELECTROCHEMICAL CELLS BASF AKTIENGESELLSCHAFT (DE) 1999-11-11 WO disclosed
WO-1999031263-A1 ALDOL CONDENSATIONS BY CATALYTIC ANTIBODIES THE SCRIPPS RESEARCH INSTITUTE (US) 1999-06-24 WO disclosed
EP-0880526-A1 HETEROCYCLE-CONDENSED MORPHINOID DERIVATIVES (II) Smithkline Beecham S.p.A. (IT) 1998-12-02 EP disclosed
WO-1997025331-A1 HETEROCYCLE-CONDENSED MORPHINOID DERIVATIVES (II) SMITHKLINE BEECHAM S.P.A. (IT) 1997-07-17 WO disclosed
EP-0049448-B1 BETA-LACTAM ANTIBIOTICS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM BAYER AG (DE) 1988-08-24 EP disclosed
US-4416880-A β-Lactam antibiotics and compositions containing the same BAYER AKTIENGESELLSCHAFT (DE) 1983-11-22 US disclosed
EP-0049448-A2 Beta-lactam antibiotics, process for their preparation and compositions containing them BAYER AG (DE) 1982-04-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250093270-A1 Method for Detecting Enzyme Activity and Fluorescent Probe Used in Said Method ACHE, BCHE, SCLY LAP3 228/4885TSHR 1246/4885MEN1 1554/4885
US-20260002280-A1 COMPOSITION FOR TIN OR TIN ALLOY ELECTROPLATING COMPRISING LEVELING AGENT NRAS, TLN1, CLIC1 LAP3 4282/4885TSHR 1731/4885MEN1 126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.